AIM
ANGO icon

Acrospire Investment Management’s AngioDynamics ANGO Stock Holding History

Acrospire Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,915
Closed -$145K – 76
2017
Q2 		$145K Buy
8,915
+317
+4% +$5.01K 0.14% 81
2017
Q1 		$149K Buy
+8,598
New +$144K 0.12% 122
2016
Q4 		– Sell
-15,771
Closed -$277K – 2178
2016
Q3 		$277K Sell
15,771
-100
-0.6% -$1.62K 0.18% 31
2016
Q2 		$228K Sell
15,871
-8,923
-36% -$112K 0.17% 35
2016
Q1 		$305K Buy
+24,794
New +$274K 0.21% 25

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Acrospire Investment Management's ANGO Position: Q3 2017 in Review

Acrospire Investment Management sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 8,915 shares — an estimated $145K sold.

Acrospire Investment Management first reported a position in ANGO in Q1 2016 and held it in 5 quarters. The position peaked at $305K in Q1 2016. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

  • Acrospire Investment Management reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 8,915 AngioDynamics shares in Q3 2017, an estimated $145K.
  • Acrospire Investment Management first reported a position in AngioDynamics in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's AngioDynamics position peaked at $305K in Q1 2016.
  • 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.